Price $55.28 |
Market Cap
26.13B
|
Sector All |
Div. Growth
6.60%
|
|
P/E
37.2
|
P/B
16.02
|
P/S
7.94
|
Dividend %
1.20%
|
|
P/CF
388.7
|
P/FCF
71.6
|
Op. Cash Flow
800K
|
FCF
0.7
|
|
Op. Margin
34.40%
|
Net Margin
25.10%
|
ROE
55.60%
|
ROI
20.00%
|
|
ROA
16.30%
|
EPS Growth
16.80%
|
Current Ratio
3.9
|
Debt/Equity
139.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| BIQI International Holdings Co (BIQI) | $0.69 | - | - | 7.2M | Strong Buy |
| Pyxus International Inc (PYX) | $15.11 | - | - | 134.9M | Strong Buy |
| PURE Bioscience (PURE) | $0.30 | - | - | 29.8M | Strong Buy |
| ProPhase Labs Inc (PRPH) | $2.05 | - | - | 26.6M | Strong Buy |
| Dougherty's Pharmacy Inc (MYDP) | $0.09 | - | - | 2.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
